Research ArticleRheumatoid Arthritis
Open Access
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen, Mark C. Genovese, Tsutomu Takeuchi, David L. Hyslop, William L. Macias, Terence Rooney, Lei Chen, Christina L. Dickson, Jennifer Riddle Camp, Tracy E. Cardillo, Taeko Ishii and Kevin L. Winthrop
The Journal of Rheumatology January 2019, 46 (1) 7-18; DOI: https://doi.org/10.3899/jrheum.171361
Josef S. Smolen
From the Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna,
Austria; Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, California,
USA; Division of Rheumatology, Department of Internal Medicine, Keio University, Tokyo,
Japan; Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana,
USA; Lilly Research Laboratories, Eli Lilly and Co., Kobe,
Japan; Oregon Health Sciences University, Portland, Oregon,
USA.
Mark C. Genovese
Tsutomu Takeuchi
David L. Hyslop
William L. Macias
Terence Rooney
Lei Chen
Christina L. Dickson
Jennifer Riddle Camp
Tracy E. Cardillo
Taeko Ishii
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- Ramiro S,
- Sepriano A,
- Chatzidionysiou K,
- Nam JL,
- Smolen JS,
- van der Heijde D,
- et al.
- 4.↵
- Fridman JS,
- Scherle PA,
- Collins R,
- Burn TC,
- Li Y,
- Li J,
- et al.
- 5.↵
- Iwata S,
- Tanaka Y
- 6.↵
- 7.↵
- Taylor PC,
- Keystone EC,
- van der Heijde D,
- Weinblatt ME,
- Del Carmen Morales L,
- Reyes Gonzaga J,
- et al.
- 8.↵
- 9.↵
- Dougados M,
- van der Heijde D,
- Chen YC,
- Greenwald M,
- Drescher E,
- Liu J,
- et al.
- 10.↵
- Fleischmann R,
- Schiff M,
- van der Heijde D,
- Ramos-Remus C,
- Spindler A,
- Stanislav M,
- et al.
- 11.
- Payne C,
- Zhang X,
- Shahri N,
- Williams W,
- Cannady E
- 12.
- Keystone EC,
- Taylor PC,
- Drescher E,
- Schlichting DE,
- Beattie SD,
- Berclaz PY,
- et al.
- 13.↵
- Tanaka Y,
- Emoto K,
- Cai Z,
- Aoki T,
- Schlichting D,
- Rooney T,
- et al.
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- Singh JA,
- Saag KA,
- Bridges SL Jr,
- Akl AE,
- Bannuru RR,
- Sullivan MC,
- et al.
- 18.↵
- 19.↵Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
- 20.↵
- National Cancer Institute
- 21.↵
- Howlader N,
- Noone AM,
- Krapcho M,
- Miller D,
- Bishop K,
- Kosary CL,
- Yu M,
- et al.
- 22.↵
- U.S. Department of Health and Human Services;
- Food and Drug Administration;
- Center for Drug Evaluation and Research (CDER);
- Center for Biologics Evaluation and Research (CBER)
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- Wollenhaupt J,
- Silverfield J,
- Lee EB,
- Curtis JR,
- Wood SP,
- Soma K,
- et al.
- 27.↵
- Cohen SB,
- Tanaka Y,
- Mariette X,
- Curtis JR,
- Lee EB,
- Nash P,
- et al.
- 28.↵
- Burmester GR,
- Panaccione R,
- Gordon KB,
- McIlraith MJ,
- Lacerda AP
- 29.↵
- 30.↵
- 31.↵
- Boyle DL,
- Soma K,
- Hodge J,
- Kavanaugh A,
- Mandel D,
- Mease P,
- et al.
- 32.↵
- Genovese MC,
- Schiff M,
- Luggen M,
- Becker JC,
- Aranda R,
- Teng J,
- et al.
- 33.↵
- Dixon WG,
- Hyrich KL,
- Watson KD,
- Lunt M,
- Galloway J,
- Ustianowski A,
- et al.
- 34.↵
- Winthrop KL,
- Novosad SA,
- Baddley JW,
- Calabrese L,
- Chiller T,
- Polgreen P,
- et al.
- 35.↵
- Winthrop KL,
- Park SH,
- Gul A,
- Cardiel MH,
- Gomez-Reino JJ,
- Tanaka Y,
- et al.
- 36.↵
- Seong SS,
- Choi CB,
- Woo JH,
- Bae KW,
- Joung CL,
- Uhm WS,
- et al.
- 37.↵
- Yamaoka K
- 38.↵
- Cohen S,
- Radominski SC,
- Gomez-Reino JJ,
- Wang L,
- Krishnaswami S,
- Wood SP,
- et al.
- 39.↵
- Winthrop KL
- 40.↵
- Khamashta M,
- Merrill JT,
- Werth VP,
- Furie R,
- Kalunian K,
- Illei GG,
- et al.
- 41.↵
- Furie R,
- Khamashta M,
- Merrill JT,
- Werth VP,
- Kalunian K,
- Brohawn P,
- et al.
- 42.↵
- 43.↵
- van Assen S,
- Agmon-Levin N,
- Elkayam O,
- Cervera R,
- Doran MF,
- Dougados M,
- et al.
- 44.↵
- Curtis JR,
- Lee EB,
- Martin G,
- Mariette X,
- Terry KK,
- Chen Y,
- et al.
- 45.↵
- Curtis JR,
- Lee EB,
- Kaplan IV,
- Kwok K,
- Geier J,
- Benda B,
- et al.
- 46.↵
- Kim SC,
- Schneeweiss S,
- Liu J,
- Solomon DH
- 47.↵
- Ogdie A,
- Kay McGill N,
- Shin DB,
- Takeshita J,
- Jon Love T,
- Noe MH,
- et al.
- 48.↵
- Romero-Diaz J,
- Garcia-Sosa I,
- Sanchez-Guerrero J
- 49.↵
- Xie F,
- Yun H,
- Bernatsky S,
- Curtis JR
- 50.↵
- U.S. Department of Health and Human Services;
- Food and Drug Administration;
- Center for Drug Evaluation and Research (CDER);
- Center for Biologics Evaluation and Research (CBER)
In this issue
The Journal of Rheumatology
Vol. 46, Issue 1
1 Jan 2019
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen, Mark C. Genovese, Tsutomu Takeuchi, David L. Hyslop, William L. Macias, Terence Rooney, Lei Chen, Christina L. Dickson, Jennifer Riddle Camp, Tracy E. Cardillo, Taeko Ishii, Kevin L. Winthrop
The Journal of Rheumatology Jan 2019, 46 (1) 7-18; DOI: 10.3899/jrheum.171361
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen, Mark C. Genovese, Tsutomu Takeuchi, David L. Hyslop, William L. Macias, Terence Rooney, Lei Chen, Christina L. Dickson, Jennifer Riddle Camp, Tracy E. Cardillo, Taeko Ishii, Kevin L. Winthrop
The Journal of Rheumatology Jan 2019, 46 (1) 7-18; DOI: 10.3899/jrheum.171361